Sinocare Inc Asset Resilience Ratio
Sinocare Inc asset resilience ratio. Sinocare Inc (300298) has an Asset Resilience Ratio of 3.53% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Sinocare Inc to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sinocare Inc (2008–2024)
Asset resilience ratio of Sinocare Inc from 2008 to 2024. This chart shows how Sinocare Inc's Asset Resilience Ratio has changed over time. Read 300298 liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sinocare Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Sinocare Inc's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥220.56 Million | 3.53% |
| Total Liquid Assets | CN¥220.56 Million | 3.53% |
Asset Resilience Insights
- Limited Liquidity: Sinocare Inc maintains only 3.53% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Sinocare Inc Industry Peers by Asset Resilience Ratio
Compare Sinocare Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Applied BioCode
TW:6598 |
Medical Devices | 9.75% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Radiant Innovation
TWO:3373 |
Medical Devices | 0.82% |
|
Impedimed Ltd
AU:IPD |
Medical Devices | 46.15% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Sinocare Inc Asset Resilience Ratio by Year (2008–2024)
Sinocare Inc asset resilience ratio by year from 2008 to 2024. The table below shows the annual Asset Resilience Ratio data for Sinocare Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.80% | CN¥110.00 Million ≈ $16.10 Million |
CN¥6.10 Billion ≈ $892.27 Million |
+1.30pp |
| 2023-12-31 | 0.51% | CN¥30.00 Million ≈ $4.39 Million |
CN¥5.93 Billion ≈ $867.30 Million |
-0.22pp |
| 2021-12-31 | 0.72% | CN¥30.00 Million ≈ $4.39 Million |
CN¥4.15 Billion ≈ $607.79 Million |
-10.89pp |
| 2017-12-31 | 11.61% | CN¥193.11 Million ≈ $28.26 Million |
CN¥1.66 Billion ≈ $243.32 Million |
-0.66pp |
| 2016-12-31 | 12.27% | CN¥180.80 Million ≈ $26.46 Million |
CN¥1.47 Billion ≈ $215.62 Million |
-2.17pp |
| 2015-12-31 | 14.44% | CN¥192.66 Million ≈ $28.19 Million |
CN¥1.33 Billion ≈ $195.21 Million |
-1.25pp |
| 2014-12-31 | 15.69% | CN¥190.14 Million ≈ $27.82 Million |
CN¥1.21 Billion ≈ $177.32 Million |
+15.64pp |
| 2009-12-31 | 0.06% | CN¥39.42K ≈ $5.77K |
CN¥71.26 Million ≈ $10.43 Million |
+0.01pp |
| 2008-12-31 | 0.04% | CN¥12.94K ≈ $1.89K |
CN¥29.34 Million ≈ $4.29 Million |
-- |
About Sinocare Inc
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more